Amebiasis, a global intestinal parasitic disease, is due to Entamoeba histolytica. This parasite, which feeds on bacteria in the large intestine of its human host, can trigger a strong inflammatory response upon invasion of the colonic mucosa. Whereas information about the mechanisms which are used by the parasite to cope with oxidative and nitrosative stresses during infection is available, knowledge about the contribution of bacteria to these mechanisms is lacking. In a recent study, we demonstrated that enteropathogenic Escherichia coli O55 protects E. histolytica against oxidative stress. Resin-assisted capture (RAC) of oxidized (OX) proteins coupled to mass spectrometry (OX-RAC) was used to investigate the oxidation status of cysteine residues in proteins present in E. histolytica trophozoites incubated with live or heat-killed E. coli O55 and then exposed to H2O2-mediated oxidative stress. We found that the redox proteome of E. histolytica exposed to heat-killed E. coli O55 is enriched with proteins involved in redox homeostasis, lipid metabolism, small molecule metabolism, carbohydrate derivative metabolism, and organonitrogen compound biosynthesis. In contrast, we found that proteins associated with redox homeostasis were the only OX-proteins that were enriched in E. histolytica trophozoites which were incubated with live E. coli O55. These data indicate that E. coli has a profound impact on the redox proteome of E. histolytica. Unexpectedly, some E. coli proteins were also co-identified with E. histolytica proteins by OX-RAC. We demonstrated that one of these proteins, E. coli malate dehydrogenase (EcMDH) and its product, oxaloacetate, are key elements of E. coli-mediated resistance of E. histolytica to oxidative stress and that oxaloacetate helps the parasite survive in the large intestine. We also provide evidence that the protective effect of oxaloacetate against oxidative stress extends to Caenorhabditis elegans.
Entamoeba histolytica is a unicellular parasite which infects millions of humans worldwide via contaminated food and water. It resides in the colon and most infected individuals are asymptomatic. In some people, the parasite can spread into both intestinal and extraintestinal tissues, and results in amebiasis. E. histolytica feeds on bacteria in the colonic microflora. Since changes in the composition of the colonic microflora coincide with the onset of symptomatic amebiasis in affected individuals, a potential role of this microflora in disease manifestation has been suggested. Some modulating effects of the intestinal bacteria and the nature of the native intestinal flora on amebic virulence have been reported, but the exact mechanisms have not been described. Here, we report that E. coli confers increased resistance against oxidative stress to the parasite via the production of oxaloacetate. This antioxidant metabolite is the result of the oxidation of malate by malate dehydrogenase. Our results indicate that E. histolytica can use oxaloacetate of bacterial origin to increase its resistance against oxidative stress and that this oxaloacetate promotes its survival in the large intestine of mice with experimentally-induced amebiasis. We also present evidence that oxaloacetate can protect Caenorhabditis elegans, another bacteria-feeding organism, against oxidative stress.
Citation: Shaulov Y, Shimokawa C, Trebicz-Geffen M, Nagaraja S, Methling K, Lalk M, et al. (2018) Escherichia coli mediated resistance of Entamoeba histolytica to oxidative stress is triggered by oxaloacetate. PLoS Pathog 14(10): e1007295. https://doi.org/10.1371/journal.ppat.1007295
Editor: William A. Petri Jr., University of Virginia, UNITED STATES
Received: June 1, 2018; Accepted: August 25, 2018; Published: October 11, 2018
Copyright: © 2018 Shaulov et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This study was supported by the Israel Ministry of Health within the framework ERA-NET Infect-ERA (031L0004) (AMOEBAC project) and grants from the Israel Science Foundation (ISF) (260/16), Rappaport Institute, and U.S.-Israel Binational Science Foundation (BSF) (2015211) to SA, the German Ministry of Education and Science BMBF within the framework ERA-NET Infect-ERA (031L0004) (AMOEBAC project) to ML, the Israeli Centers of Research Excellence (I-CORE) program (Center No. 1796/12) and Israel Cancer Research Fund to ATL, the Grants-in-Aid for International Scientific Research (B) from JSPS (15H05274) and Grants-in-Aid for Scientific Research (C) (15K08441) to HH, Grant-in Aid for Young Scientists (B) from Ministry of Education, Culture, Sports, Science, and Technology (26870849), scientific grants from the Ohyama Health Foundation, the Ichiro Kanehara Foundation, and the Takeda Science Foundation to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Entamoeba histolytica is a protozoan parasite, which inhabits the gastrointestinal tract, and an E. histolytica infection is a substantial health risk in almost all countries where the barrier between food and water and human feces is inadequate. The major clinical manifestations of an E. histolytica infection are amebic colitis, amebic liver abscess, and extraintestinal amebiasis. It is estimated that amebiasis accounted for 55500 deaths and 2.237 million disability-adjusted life years (the sum of years of life lost and years lived with disability) in 2010. This mortality rate makes an E. histolytica infection the second leading cause of death due to a parasitic infection. E. histolytica is a dimorphic organism whose life cycle has two stages: a trophozoite, a cell-invasive form which can be found in the human intestine, and a cyst, an infective form which is found in the external environment. The conversion between the two stages is usually reversible. Infection of the host occurs upon ingestion of water or food contaminated with cysts. After ingestion, the cysts pass through the stomach, excyst in the small intestine where they produce ameboid trophozoites, which then colonize the large intestine. In the colon, the trophozoites can either asymptomatically colonize the gut, re-encyst, and be expelled in the feces or cause invasive disease. Although the exact conditions, which trigger the onset of invasive disease, are still unknown, the interaction between the parasite’s virulence factors and the host’s response contribute to the development of disease.
The human gastrointestinal tract is a nutrient-rich environment which harbors a complex and dynamic population of 38 trillion microbes . About 500–1000 bacterial species colonize the adult intestine, with 30–40 species comprising up to 97% of the total population,. The majority reside in the colon where densities approach 1011 - 1012 cells/ml. Following colonization of the gut, the parasite is constantly interacting with the gut microbiota whose contribution to the manifestation of disease is poorly understood. The trophozoites are quite selective in their interactions with different bacterial species and only those bacteria which have the appropriate recognition molecules get attached to the trophozoites and are ingested. The relationship between E. histolytica and the gut microbiota was the subject of many studies which concluded that the gut microbiota affects greatly several aspects of E. histolytica’s physiology[10, 11],[12, 13],. In areas where amebiasis is endemic, mixed intestinal infections of E.histolytica and enteropathogenic Escherichia coli (EPEC) are common. Bacteria in the intestinal flora including EPEC have been proposed as inducers of amebic virulence, but the causes or mechanisms which are responsible for the induction are still undetermined [16, 17]. The presence of enteropathogenic bacteria or the presence of Prevotella copri, a normal component of the gut microbiota, has been correlated to a symptomatic outcome of E. histolytica infection in young children. In contrast, mice which were inoculated with commensal Clostridia spp. and segmented filamentous bacteria are protected against an E. histolytica infection. Amebiasis is marked by acute inflammation with the release of cytokines (tumor necrosis factor alpha (TNFα), interleukin 8 (IL-8), IL-1β, interferon gamma (IFN-γ), reactive oxygen species (ROS), and nitric oxide (NO) from activated cells of the immune system. Depending on their concentration, ROS and NO have been reported to (a) trigger stress responses, (b) control the activity of E. histolytica virulence factors, and (c) be cytotoxic ,[21–24]. Recent evidence suggests that the gut microbiome can control oxidative stress and inflammation in the gut [25–29]. Recently, we demonstrated that enteropathogenic Escherichia coli O55 protects E. histolytica against oxidative stress and that this bacterium exerts a strong influence on the transcriptome of oxidatively stressed parasites . In this report, we inform on the mechanism of E. coli-mediated resistance of E. histolytica to oxidative stress by examining the redox proteome of the parasite exposed to E. coli and oxidative stress. We found that live E. coli trigger significant changes in the redox proteome profile of oxidatively stressed E. histolytica. We also found that E. coli malate dehydrogenase (MDH) and its product, oxaloacetate, are essential for protecting the parasite against oxidative stress.
OX-RAC analysis of OX-proteins in E. histolytica trophozoites preincubated with E. coli O55 and then exposed to oxidative stress
The results of our recent investigation indicate that preincubation of E. histolytica trophozoites with live E. coli O55, but not with heat-killed E. coli O55, confers resistance to H2O2-induced oxidative stress to the parasite . In order to obtain insights into the mechanisms of survival of oxidatively stressed E. histolytica trophozoites, we did an OX-RAC analysis of the proteins in E. histolytica trophozoites which were exposed to live or heat-killed E.coli O55 for 30 minutes and then exposed to 2.5 mM H2O2 for 60 minutes at 37°C (Fig 1A). The purification of OX-proteins by OX-RAC analysis, which has been previously described in detail , has three steps: (i) blocking by N-ethylmaleimide (NEM) of non-oxidized cysteine residues present in E. histolytica proteins; (ii) reduction of oxidized cysteine residues with dithiothreitol (DTT); and (iii) binding of the cysteine residues reduced by DTT to a thiopropyl sepharose resin. The OX-proteins are then eluted from the thiopropyl sepharose resin and identified by mass spectrometry. We identified 329 OX-proteins in those trophozoites which were exposed to heat-killed E. coli O55 and H2O2 (THK) and 300 OX-proteins in those trophozoites which were exposed to live E. coli O55 and H2O2 (TL) (S1 & S2 Tables). Using the PANTHER sequence classification tool, we found that a third of the OX-proteins are shared by THK and TL ((Fig 1B and S3 & S4 Tables). We also found that OX-proteins in the following biological processes were significantly enriched in THK (Fig 1C and S5 Table): redox homeostasis (GO:0045454) (exemplified by thioredoxin EHI_004490 or EHI_006700), lipid metabolism (GO:0044255) (exemplified by 3-ketoacyl-CoA synthase EHI_111000 or geranylgeranyl pyrophosphate synthase EHI_105060), small molecule metabolism (GO:0044281) (exemplified by glyceraldehyde-3-phosphate dehydrogenase EHI_008200 and threonine dehydratase EhTD1 EHI_092390), carbohydrate derivative metabolism (GO:1901135) (exemplified by mannosyltransferase EHI_103330 and glucosidase 2 subunit beta EHI_135420), and organonitrogen compound biosynthesis (GO:1901566) (exemplified by alpha-1,3-mannosyltransferase ALG2, EHI_162230 and dolichyl-diphosphooligosaccharide—protein glycosyltransferase subunit 1 EHI_029540). In contrast, we found that OX-proteins in the following biological process were significantly enriched in TL: redox homeostasis (GO:0045454) (exemplified by thioredoxin EHI_004490 or EHI_006700) (Fig 1C and S5 Table). The small number of shared OX-proteins and biological processes in THK and TL suggests that exposure of the parasite to live E. coli influences the parasite’s redox proteome. We also found 70 E. coli proteins that were co-purified with E. histolytica OX-proteins (S6 Table). It has been previously reported that a catalase-deficient strain of Salmonella dysenteriae, which cannot decompose H2O2 to water and oxygen, cannot boost the virulence of oxidatively stressed trophozoites whereas a wild-type S. dysenteriae does . Accordingly, we posited that those E. coli proteins which are involved in the bacterium’s resistance to oxidative stress also participate in the parasite’s protective mechanism against oxidative stress. Five of the 70 E.coli proteins were selected because of their participation to the resistance of E. coli to oxidative stress, namely, 60 kDa chaperonin (it protects proteins which are denatured by oxidative stress from misfolding and aggregating [33, 34]); superoxide dismutase (it catalyzes the decomposition of the superoxide free radical ); MDH (it catalyzes the formation of oxaloacetate from malate and it protects E. coli against oxidative stress ); aspartate ammonia-lyase (it catalyzes the formation of ammonia and promotes the formation of antioxidant polyamines in E.coli  ), and alkyl hydroperoxide reductase subunit C (it catalyzes the NADH-dependent reduction of H2O2 to H2O ). We then investigated the ability of E.coli K12 and the following E. coli mutants: 60 kDa chaperonin (JW 4103- Δ gro), superoxide dismutase (JW1648- Δsod), MDH (JW 3205- Δ mdh), aspartate ammonia-lyase (JW4099- ΔaspA), and alkyl hydroperoxide reductase subunit C (JW0598- Δ ahpc) to protect E. histolytica against H2O2-induced oxidative stress. We found that the levels of protection that are conferred by E. coli O55  and E. coli K12 on oxidatively stressed E. histolytica trophozoites are similar (Table 1). Among the E. coli K12 mutants, we found that the MDH mutant E. coli JW 3205 was the only one that did not protect E. histolytica against H2O2-induced oxidative stress (Table 1).
A. Silver staining of oxidized (OX)-proteins. E. histolytica trophozoites strain HM-1:IMSS were preincubated with live or heat-killed E. coli O55 for 30 minutes and later exposed to H2O2 (2.5 mM H2O2) for 60 minutes. OX-proteins in the cell lysates were subjected to resin-assisted capture (RAC) in the presence of 10 mM DTT (+DTT) or the absence of DTT (–DTT). 1. E. histolytica + heat- killed E. coli O55 + H2O2 (2.5 mM H2O2) (-DTT); 2. E. histolytica + heat-killed E. coli O55 + H2O2 (2.5 mM H2O2) (+DTT); 3 E. histolytica + live E. coli O55 + H2O2 (2.5 mM H2O2) (-DTT); 4. E. histolytica + live E. coli O55 + H2O2 (2.5 mM H2O2) (+DTT); B. Functional categories of OX- proteins in E. histolytica trophozoites incubated with heat-killed E. coli and in E. histolytica trophozoites incubated with live E. coli. OX-proteins in E. histolytica were classified according to the protein class they encode using the PANTHER sequence classification tool and their biological role. C. Results of a PANTHER statistical overrepresentation test which compared OX-proteins in E. histolytica trophozoites preincubated with heat-killed E. coli and OX proteins in E. histolytica trophozoites preincubated with live E. coli.
E. coli MDH is essential for protecting E. histolytica against H2O2-induced oxidative stress
In order to demonstrate whether MDH is essential for protecting E. histolytica against H2O2-induced oxidative stress, E. coli JW 3205 was complemented with a plasmid which harbored wild-type E. coli mdh. MDH activity was determined in the whole lysate of E. coli K12, E. coli JW 3205, and E. coli JW 3205 complemented with mdh (Table 2). We found MDH activity in E. coli K12 and in E. coli JW 3205 complemented with mdh but not in E. coli JW 3205 (Table 2). We also found that E. coli JW 3205 complemented with mdh, but not E. coli JW 3205, protects E. histolytica against H2O2-induced oxidative stress (Table 1). MDH catalyzes the reversible transformation of malate into oxaloacetate and it has been reported that oxaloacetate in millimolar concentrations protects E. coli against H2O2-induced oxidative stress. In order to test the hypothesis that oxaloacetate is essential for protecting E. histolytica against H2O2-induced oxidative stress, we determined the viability of E. histolytica trophozoites first exposed to different concentrations of oxaloacetate (0–2 mM for 15 minutes) and then to H2O2 (2.5 mM for one hour). We found that oxaloacetate at concentrations higher than 0.25 mM protects the parasite against H2O2-induced oxidative stress (Table 1 and S1 Fig). We also found that malate (0.5 mM) has no effect on the resistance of the parasite to H2O2-induced oxidative stress (Table 1). Paraquat has been previously used to trigger oxidative stress in E.histolytica. In order to demonstrate whether oxaloacetate protects the parasite against paraquat, trophozoites were incubated with oxaloacetate (2 mM) and then exposed to paraquat (2.5 mM). We found that oxaloacetate does not protect the parasite against paraquat (S2 Fig).
Next, we tested whether E. coli O55 also protects E. histolytica against nitrosative stress. For this purpose, we exposed E. histolytica trophozoites to the nitric oxide (NO) donor, S-nitrosoglutathione (350 μM for 120 minutes). We found that E. histolytica trophozoites exposed to live or heat-killed E. coli O55 are not protected against S-nitrosoglutathione-induced nitrosative stress (S3 Fig). We also found that oxaloacetate (2 mM) does not protect the parasite against S-nitrosoglutathione-induced nitrosative stress (S3 Fig).
It has been reported that E.coli can boost the virulence of E.histolytica and that this boosting is contact dependent. However, it is not known whether contact between E. coli and the parasite is necessary for protecting the parasite against H2O2-induced oxidative stress. This question was addressed by physically separating the trophozoites from E. coli O55 or E. coli K12 with a polycarbonate insert (0.4 μm) prior to the exposure of the parasite to H2O2. We found that E. coli O55 and E. coli K12 inside the polycarbonate insert protect the parasite against H2O2-induced oxidative stress (S4 Fig).
Since E.coli MDH (EcMDH), which is secreted by E.coli, is essential for protecting E. histolytica against H2O2-induced oxidative stress (Table 2) and this protection is contact independent (S4 Fig), we posited that EcMDH contributes to the resistance of E. histolytica to H2O2-induced oxidative stress. This hypothesis was tested by first incubating E. histolytica with commercial His-tagged EcMDH and then exposing the parasite to H2O2-induced oxidative stress. As a prerequisite to this experiment, we checked the activity of the commercial His-tagged EcMDH and found that the recombinant protein is catalytically active (Table 2). We found that the presence of His-tagged EcMDH did not protect the parasite against H2O2-induced oxidative stress (Fig 2). However, we found that the parasite is protected against H2O2-induced oxidative stress when the parasite is incubated with both His-tagged EcMDH (1.5 μg) and L-malate (50 mM) prior to its exposure to H2O2-induced oxidative stress (Fig 2).
The viability (%) of E. histolytica trophozoites preincubated with His-tagged EcMDH (1.5 μg/ml) and malate (50 mM) was significantly higher than that of the control group (E. histolytica trophozoites incubated with the His-tagged EcMDH without malate). Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice. Unpaired t-test, ***P ≤ 0.0001.
Expression of E. coli MDH in E. histolytica does not protect the parasite against H2O2-induced oxidative stress
No MDH activity was detected in a whole lysate and the secretory products of control E. histolytica trophozoites  (Table 2) despite the presence of six putative MDH genes in the genome of the parasite  (EHI_152670, EHI_067860, EHI_165350, EHI_030810, EHI_092450 and EHI_014410) and one MDH in the secretome of E. histolytica  (EHI_092450). When the E. histolytica MDH (EhMDH, EHI_067860) is overexpressed in E.coli, its activity is less than 40% of its E. coli homolog (Table 2). These results raise a question on whether the parasite can express an active MDH. To answer this question, E. histolytica trophozoites were complemented with HA-tagged EcMDH. The expression of HA-tagged EcMDH in the trophozoites was confirmed by western blotting (Fig 3A) and detecting MDH activity in their whole lysates (Table 2). When we compared the resistance of HA-tagged EcMDH trophozoites to H2O2-induced oxidative stress (Fig 3B) and trophozoites transformed with the pcontrol plasmid, we found that the sensitivity of the HA-tagged EcMDH trophozoites and the pcontrol trophozoites to H2O2-induced oxidative stress was identical. Incubation of the HA-tagged EcMDH trophozoites in presence of malate (2 mM) prior to their exposure to H2O2-induced oxidative stress did not increase their resistance to H2O2-induced oxidative stress (Fig 3B).
A. Western blot analysis was performed on total protein extracts that were prepared from pcontrol E. histolytica trophozoites (lane 1) and HA-tagged EcMDH trophozoites. The proteins were separated on 12% SDS-PAGE gels and analyzed by western blotting using an HA antibody or actin antibody. B. The viability of E. histolytica trophozoites was determined after their exposure to 2.5 mM H2O2 for one hour at 37°C. Some experimental groups (malate) were preincubated with 50 mM malate for 15 minutes before being exposed to H2O2. Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice.
The intracellular concentration of oxaloacetate was determined in pcontrol trophozoites, HA-tagged EcMDH trophozoites, E. coli K12, and E.coli JW 3205. We were able to detect 12.7 nmol oxaloacetate/mg proteins in E. coli K12, but no oxaloacetate was detected in the pcontrol trophozoites, the HA-tagged EcMDH trophozoites, and E. coli JW 3205. No oxaloacetate was also detected in the supernatant of the growth medium of E. coli or E. histolytica.
Oxaloacetate reduces the formation of OX-proteins
Ketoacids act as non-enzymatic antioxidants due to their ability to scavenge H2O2 [46, 47]. We determined the amount of H2O2 in presence or absence of oxaloacetate and confirmed that the amount of H2O2 dropped in presence of oxaloacetate (S5 Fig). The antioxidant property of oxaloacetate was also evaluated by determining the formation of OX-proteins in trophozoites exposed to H2O2 and trophozoites exposed to H2O2 and oxaloacetate using OX-RAC (Fig 4; left panel). The amount of OX-proteins in those trophozoites exposed to H2O2 was four times bigger than that in those trophozoites exposed to H2O2 and oxaloacetate. Gal/GalNac lectin is a surface protein which is essential for the binding of the parasite to target cells  and its binding activity is inhibited by the oxidation of the cysteine residues present in the carbohydrate recognition domain of the heavy subunit Gal/GalNAc lectin (Hgl) (EHI_012270) . We decided to determine the redox status of Hgl in trophozoites exposed to H2O2 and trophozoites exposed to H2O2 and oxaloacetate by western blotting of the OX-proteins (Fig 4; right panel). We detected a strong Hgl signal in those trophozoites exposed to H2O2 whereas Hgl is barely detectable in those trophozoites exposed to H2O2 and oxaloacetate. Collectively, these results indicate that oxaloacetate reduces the formation of OX-proteins in trophozoites exposed to H2O2.
E. histolytica trophozoites strain HM-1:IMSS were exposed to H2O2 (2.5 mM) or to H2O2 (2.5 mM) and oxaloacetate (2 mM) for 30 minutes. OX-proteins in the cell lysates were subjected to resin-assisted capture (RAC) in the presence of 10 mM DTT (+DTT) or the absence of DTT (–DTT). 1. E. histolytica + H2O2 (2.5 mM)(-DTT); 2. E. histolytica + H2O2 (2.5 mM)(+DTT); 3 E. histolytica + H2O2 (2.5 mM) + oxaloacetate (2 mM) (-DTT); 4. E. histolytica + H2O2 (2.5 mM) +oxaloacetate (2 mM) (+DTT). Left panel: Silver staining of OX-proteins after RAC. The intensity of the protein bands were quantified by densitometry using Image J software . This image is representative of two independent experiments. Right panel: Western blot analysis was performed on OX-proteins after RAC. The proteins were separated on 8% SDS-PAGE gels and analyzed by western blotting using a polyclonal Gal/GalNAc lectin antibody. The figure displays a representative result from two independent experiments. The input control (amount of Hgl in cell lysates of trophozoites exposed to H2O2 (2.5 mM) or to H2O2 (2.5 mM) and oxaloacetate (2 mM) for 30 minutes before RAC) is shown in S7 Fig.
Oxaloacetate prevents the loss of the cytopathic activity of oxidatively stressed E. histolytica trophozoites
It has been previously reported that H2O2-induced oxidative stress impairs the cytopathic activity of E. histolytica . We found that the cytopathic activity of E. histolytica trophozoites incubated with E. coli K12 or E. coli JW 3205 complemented with mdh was not impaired when they were exposed to H2O2-induced oxidative stress and was impaired when they were exposed to E. coli JW 3205 (Fig 5A). In order to test whether oxaloacetate can protect the cytopathic activity of oxidatively stressed E. histolytica trophozoites, E. histolytica trophozoites were exposed or not exposed to oxaloacetate prior to their exposure to H2O2 (Fig 5B). We found that the cytopathic activity of the oxidatively stressed E. histolytica trophozoites is substantially impaired, but this impairment does not occur when the parasite was preincubated with oxaloacetate before being exposed to H2O2 (Fig 5B).
Effect of H2O2-induced oxidative stress, E. coli and oxaloacetate on the cytopathic activity of E. histolytica: A Cytopathic activity of E. histolytica trophozoites was measured by their ability to destroy a monolayer of HeLa cells. E. histolytica trophozoites were preincubated with E.coli O55 for 15 minutes before the addition of 2.5 mM H2O2 (HOS: H2O2-induced oxidative stress). Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice. Trophozoites versus (vs) Trophozoites + H2O2-induced oxidative stress (Unpaired t-test, **P ≤0.01), Trophozoites vs Trophozoites+ E.coli K12 (Unpaired t-test, ***P ≤0.001), Trophozoites vs Trophozoites + E.coli JW3205 + H2O2-induced oxidative stress (Unpaired t-test, **P ≤0.01) B. E. histolytica trophozoites were preincubated with 0.5 mM oxaloacetate for 15 minutes before the addition of H2O2. Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice. Unpaired t-test, *** P ≤0.001.
Oxaloacetate inhibits the amebicidal activity of activated murine macrophages
The amebicidal activity of murine macrophages depends on the formation of reactive oxygen and nitrogen species and the addition of catalase to the culture medium of activated murine macrophages reduces their amebicidal activity . Based on these data, we determined the effect of oxaloacetate on the amebicidal activity of activated murine macrophages (Fig 6). We found that the amebicidal activity of activated murine macrophages is substantially impaired when these macrophages were incubated with oxaloacetate (Fig 6).
Oxaloacetate helps the parasite to survive within the mouse large intestine
The effect of oxaloacetate on the survival of E. histolytica in the large intestine was tested in a mouse strain resistant to intestinal amebiasis C57BL/6 (B6)  and in a mouse strain susceptible to intestinal amebiasis CBA/J . The survival of the parasite was determined by counting the number of trophozoites in the stool after cultivation and by amplification of E.histolytica 18S rRNA in DNA extracted from the stool by polymerase chain reaction (PCR). We found that intracecal injection of the parasite with oxaloacetate (2 mM) helps the parasite to survive in the intestine. (Fig 7A & 7B).
C57BL/6 (A) and CBA/J (B) mice were intracaecally inoculated with 1 × 106 trophozoites of E. histolytica (Eh) in the presence of oxaloacetate (2mM) (OA). E. histolytica without in vivo serial passage (NA Eh) was also used to susceptible CBA/J mice. For determining the presence of the parasite in the stool of infected mice, cultivation of stool and PCR amplification of E.histolytica 18S rRNA in DNA extracted from the stool were performed. Data are displayed as the mean ± standard deviation of six mice in one representative experiment. Asterisks indicate significant differences at P < 0.05 according to the results of an unpaired Student’s t-test.
Glycerol accumulation does not occur in E. histolytica trophozoites pretreated with oxaloacetate before their exposure to H2O2-induced oxidative stress
It has been reported that the glycolytic activities of oxidatively stressed E. histolytica trophozoites are impaired and this impairment results in a redirection of the metabolic flux toward glycerol production. Therefore, the amount of glycerol in the parasite could be used as an indicator of the level of oxidative stress sensed by the parasite. We found that the amount of glycerol in those parasites exposed to H2O2 was two-fold greater than that in the unexposed parasites (Fig 8). We also did not detect any differences in the amount of glycerol in those parasites exposed to oxaloacetate and in those trophozoites exposed to oxaloacetate and H2O2. Husain et al.  reported that the amount of isocitrate in control (unstressed) and oxidatively stressed trophozoites is similar. This finding suggests that the intracellular amount of isocitrate could be used as an internal standard for our metabolomic data in the control and oxidatively stressed trophozoites. We found no difference in the amounts of isocitrate in the oxidatively stressed and control parasites which confirmed the finding of Husain et al.  and concluded that the quality of our metabolomic data is good. (Fig 8).
Trophozoites were preincubated with 2.5 mM oxaloacetate for 30 minutes without or with the addition of H2O2 (treatment with 2.5 mM for one hour). Data are displayed as the mean ± standard deviation of three independent experiments. **** P-value < 0.0001, determined by a 2-way ANOVA (Prism), corrected with Tukey’s multiple comparisons test.
Oxaloacetate increases the survival of C. elegans exposed to H2O2
The environment in which C. elegans lives contains bacteria and C. elegans uses these bacteria as its food source. Based on our findings in E. histolytica, we tested the hypothesis that bacteria can also influence the ability of C. elegans to resist H2O2-induced oxidative stress. It has been previously reported that oxaloacetate increases the life span of C. elegans . Additionally, our knowledge on the effect of oxaloacetate on the resistance of the nematode to H2O2-induced oxidative stress is lacking. In order to fill these knowledge gaps, C. elegans at the L1 developmental stage were incubated with different concentrations of oxaloacetate and then exposed to H2O2. We found that the survival rate of those worms which were treated with oxaloacetate (2.5 mM or higher) is higher than those worms which were treated with oxaloacetate (1 mM or less) prior to their exposure to H2O2 (Fig 9A).
A. C. elegans was exposed to different concentrations of oxaloacetate in M9 medium and then to 1 mM H2O2. The curves represent the means of the survival curves from three individual experiments. Increased viability of C. elegans exposed to H2O2 can be observed when the worms were supplemented with oxaloacetate (2.5 mM and 5 mM). Control (No oxaloacetate) vs 2.5 mM oxaloacetate (Unpaired t-test, ** P ≤0.01), Control vs 5 mM oxaloacetate (Unpaired t-test, *** P ≤0.001). B. C. elegans was first exposed to E. coli K12 or E. coli JW3205 or to no bacteria in M9 medium and then to H2O2 (1 mM). The curves represent the means of the survival curves from three individual experiments. Increased viability of C. elegans exposed to H2O2 can be observed when the worms were incubated with E. coli K12 or E. coli JW3205. No bacteria (control condition) vs E. coli K12 (Unpaired t-test, *** P ≤0.001), No bacteria (control condition) vs E.coli JW3205 (Unpaired t-test, *** P ≤0.001).
C. elegans were also incubated in M9 medium without bacteria or with E. coli K12 or E. coli JW 3205 prior to their exposure to H2O2. We found that both E. coli K12 and E. coli JW 3205 protect C. elegans against H2O2 (Fig 9B) whereas only E.coli K12 protected E.histolytica against H2O2 (Table 1). These findings suggest that the mechanism of protection of C. elegans against H2O2 is more complex than that in E. histolytica and that it does not solely depend on the activity of EcMDH.
In a previous report, we informed on the results of our redox proteomics analysis of oxidatively stressed E. histolytica trophozoites . In order to understand the mechanisms of survival of E. histolytica trophozoites that were incubated with E. coli prior to their exposure to H2O2, we did a redox proteomics analysis of the parasite which was exposed first to heat-killed or live E. coli and then exposed to H2O2. The proteins involved in redox homeostasis, mainly, thioredoxin (TRX) and protein disulfide isomerase (PDI) were identified as OX-proteins in oxidatively stressed E. histolytica trophozoites which were exposed to heat-killed or live E. coli. This result indicates that the presence of heat-killed or live E. coli has no detectable effect on the oxidation status of these proteins. In previous investigations, we reported that TRX and PDI are oxidized and nitrosylated when E. histolytica trophozoites are exposed to oxidative and nitrosative stress [22, 53]. PDIs are oxidoreductases and isomerases which are involved in the unfolded protein response. In the oxidation-reduction reaction to reduce peroxyredoxin or decompose H2O2 into H2O, TRX is the first substrate to be transformed by TRX reductase (TrxR). Since TRX is susceptible to oxidation and is reduced as part of its antioxidant activity[57, 58], these properties may be reasons why TRX is oxidized in the oxidatively stressed parasite after its exposure to heat-killed or live E.coli.
We detected OX-proteins in E. histolytica trophozoites which were incubated with heat-killed E. coli and exposed to H2O2. Since these OX-proteins were not detected in E. histolytica trophozoites which were incubated with live E. coli and exposed to H2O2, their absence suggests that their oxidation in E. histolytica trophozoites depends on the presence of live E. coli. One of these OX-proteins is the 60S acidic ribosomal protein L9 which belongs to the “organonitrogen compound biosynthesis” class of proteins. In our previous investigation, we also identified the 60S acidic ribosomal protein L9 (EHI_193080) as an OX-protein. We have previously discussed that the inhibition of protein synthesis in oxidatively stressed E. histolytica trophozoites results from the oxidation of different components of the parasite’s translational machinery which includes the 60S acidic ribosomal proteins. The absence of oxidized ribosomal proteins in trophozoites which were incubated with live E. coli prior to their exposure to H2O2 suggests that the presence of live E. coli protects these proteins from oxidation. We can also deduce that this presence facilitates the survival of the oxidatively stressed parasite.
The results of previous studies have shown that a short preincubation of E. histolytica trophozoites strain HM-1:IMSS with E.coli O55 can boost the parasite’s ability to destroy monolayers of cultured cells. Our findings indicate that the impaired cytopathic activity of oxidatively stressed E. histolytica trophozoites can be regained by pre-incubating the parasite with E. coli or oxaloacetate. These results and those of others suggest that the parasite’s virulence and ability to resist oxidative stress are linked. This boosting of E. histolytica’s virulence by E.coli O55 is contact dependent and relies on the presence of galactose lectin on the parasite’s surface. We found that the protective effect of E.coli on oxidatively stressed E. histolytica trophozoites does not rely on the binding of the bacteria to the parasite but on the formation of oxaloacetate by E. coli. Pyruvate, oxalo-ketoglutarate, and other ketoacids function as non-enzymatic antioxidants due to their ability to scavenge H2O2[46, 47]. It has also been reported that ketoacids can protect E. coli, several eukaryotic cell types,, [61–63] and even whole organs, such as the heart and kidney[64–66] against oxidative stress. It is also interesting to note that the increase in the life span of C. elegans after exposure to oxaloacetate may be due to the ability of oxaloacetate to scavenge H2O2. The ability of oxaloacetate to scavenge H2O2 is supported by our findings of a reduction in (i) the amount of OX-proteins in trophozoites exposed to H2O2 and oxaloacetate; (ii) the intracellular amount of glycerol in trophozoites exposed to H2O2 and oxaloacetate and (iii) the concentration of H2O2 is reduced in presence of oxaloacetate. The mechanism of H2O2 scavenging by oxaloacetate is not compatible with the detoxification of s-nitrosothiol groups which are formed during nitrosative stress. Since it is also not compatible with the intracellular formation of superoxide by paraquat, this finding may explain why oxaloacetate cannot protect E. histolytica against nitrosative stress and oxidative stress induced by S-nitrosoglutathione and paraquat, respectively.
We found that oxaloacetate produced by E. coli protects E. histolytica against H2O2induced oxidative stress. It is possible that H2O2 is detoxified by oxaloacetate inside the bacteria. The need of an active EcMDH for protecting E. histolytica against H2O2 is supported by the results of our experiment in which we found that heat-killed E. coli are unable to protect the parasite against H2O2. It is also possible that H2O2 is detoxified by oxaloacetate which is secreted into the culture medium. To our knowledge, such secretion of oxaloacetate by E. coli and other microorganisms is not supported by the literature. Our attempts to detect oxaloacetate in the extracellular medium using metabolomics or an enzymatic-based kit failed because it is a very unstable metabolic intermediate. However, it is possible that oxaloacetate is formed extracellularly by secreted EcMDH because (i) EcMDH is part of E. coli’s secretome  and (ii) the addition of recombinant EcMDH to the medium in presence of malate confers resistance to the parasite against H2O2-induced oxidative stress (this work).
Despite the presence of six putative MDH genes in the genome of the parasite , we and others  were unable to detect any MDH activity in a total lysate of the parasite. Several different explanations may account for this experimental observation: (i) EhMDHs are very sensitive to environmental conditions and are denatured once the parasite is lysed, (ii) the parasite has lost an active MDH during the course of evolution because it can relies on malate and oxaloacetate produced by the gut microbiota and (iii) EhMDHs may have a different enzymatic activity unrelated to their metabolic function as reported for a number of E.histolytica moonlighting enzymes [41, 70]. This third hypothesis is supported by the unexpected presence of two MDHs (EHI_030810 and EHI_165350) on the parasite’s surface .
Since E. histolytica is able to express a functional EcMDH (based on the activity measured in a total lysate of the EcMDH trophozoites), its sensitivity to H2O2-induced oxidative stress was comparable to that of pcontrol trophozoites. Since oxaloacetate was not being detected in the EcMDH-overexpressing trophozoites even when malate was present in the medium, we concluded that (i) the concentration of intracellular malate in the parasite is limiting, (ii) the parasite cannot transport external malate, and (iii) EcMDH is not functional inside the parasite. Another possibility is that the newly formed oxaloacetate is quickly converted to a non-protective metabolite in the parasite. Pyruvate:ferredoxin oxidoreductase (PFOR) is an enzyme which uses oxaloacetate as an alternative substrate to pyruvate may be responsible for this conversion. Alternatively, it is possible that EcMDH is active inside the parasite, but the production of oxaloacetate is insufficient to neutralize the cytotoxic effect of H2O2. Accordingly, any neutralization or antioxidant mechanism must be operative extracellularly in order to be effective.
We found that the survival of oxaloacetate-treated parasites is better than that of parasites which were not exposed to oxaloacetate in a mouse model of amebic colitis. It has been previously shown that a strong inflammatory response occurs after injecting the parasite into the large intestine of mice . This inflammatory response is essential for killing the parasite because neutrophil-depleted or dexamethasone-treated C3H or CBA mice are more susceptible than untreated mice . It is possible that oxaloacetate neutralizes H2O2 which is produced by neutrophils inside the colon of the trophozoite-infected mice and consequently promotes the parasite’s survival. This hypothesis is supported by our in vitro data which demonstrated that the amebicidal activity of activated murine macrophages which depends on the formation of ROS and NO  is reduced in presence of oxaloacetate. The susceptibility of mice to an E.histolytica infection depends in part on the content of sialic acids in intestinal mucins and the binding of the parasite to these mucins is mediated by Hgl . The better colonization of oxaloacetate-treated parasites than untreated parasites in the large intestine of mice may be explained by the presence of a functional Hgl in the oxaloacetate-treated parasite. Specifically, Hgl in the untreated parasite is inactivated or becomes non-functional when it is oxidized .
Although we don’t know the exact concentration of oxaloacetate in the human large intestine due to the instability of oxaloacetate, the concentration of malate, its precursor, is in the millimolar range . Based on this information, it is tempting to speculate that enough oxaloacetate is produced in the human large intestine to protect the parasite against H2O2-induced oxidative stress.
To conclude, we have done the first redoxomics of E. histolytica incubated with E. coli and exposed to H2O2-induced oxidative stress. Although it is difficult to deduce from our data whether changes in the redox status of E. histolytica proteins actually occur when the parasite resides in its host, this investigation highlights that the interaction between the parasite and the gut flora is more complex than the predator-prey relationship. A complex interaction has also been recently described in C. elegans. This bacteria-feeding nematode can avoid pathogenic bacteria, such as Pseudomonas aeruginosas, by sensing some of their secondary metabolites . Other parasitic protozoa and helminths which are also in a tight relationship with the host’s intestinal microbiota may benefit from the antioxidant properties of oxaloacetate which is produced by the gut microbiota . This proposition is supported by our data about the protection of C. elegans by oxaloacetate against H2O2-induced oxidative stress. Strategies that counteract the protective effect of oxaloacetate against oxidative stress may be valuable in the treatment of amebiasis.
Materials and methods
E. histolytica culture
E.histolytica trophozoites HM-1:IMSS strain were grown under axenic condition at 37°C in Trypticase Yeast Extract Iron Serum (TYI-S-33) medium prepared according to a previously reported protocol. The trophozoites were harvested during the logarithmic phase of growth by chilling the culture tubes at 4°C and pelleted by centrifugation at 500 g for five minutes. The pellet was washed twice with ice-cold phosphate-buffered saline.
C. elegans culture and synchronization
C. elegans strain Bristol N2 were grown and maintained at 16°C on nematode growth media (NGM) agar using a previously reported protocol. E. coli OP50 was used as their food source. For synchronizing the worms, gravid adults were treated with a freshly prepared 20% sodium hypochlorite solution to isolate embryos. Embryos were then incubated overnight in M9 solution in a nutator at 20°C without food to allow hatching to the L1 developmental stage and to prevent further development. The number of worms was estimated using a hemocytometer.
Cultivation of HeLa cells
HeLa cells (a kind gift from Dr. Kleinberger, Faculty of Medicine, Technion) were maintained in continuous culture using a previously described protocol .
Transfection of E. histolytica trophozoites
The transfection of E. histolytica trophozoites was done using a previously described protocol.
Determination of the median lethal dose (LD50) of H2O2
E. histolytica trophozoites (1×106) in TYI-S-33 medium (without serum) were exposed to different concentrations of H2O2 (0-5mM) for one hour at 37°C. The viability of the trophozoites was determined by the eosin dye exclusion method.
Viability of E. histolytica exposed to paraquat
E. histolytica trophozoites were first cultivated in standard TYI-S-33 medium in 7 ml culture tubes for 12 hours at 37°C. The culture medium was then replaced with fresh and warm culture medium and paraquat (2.5 mM final concentration) was added and the culture was continued for 12 hours. The viability of the trophozoites was determined by the eosin dye exclusion method.
Viability of C. elegans exposed to H2O2
C. elegans (100 L1 larvae) after synchronization in M9 medium were placed into each well of a 24-well plate. The worms were first exposed to different concentrations of oxaloacetate (0–5 mM) for five minutes, exposed to 2.5 mM H2O2, and then incubated in an orbital shaker at 20°C for 2, 4, 6, and 24 hours. To determine their viability after each exposure time, the worms were seeded on one side of a NGM agar plate and E. coli OP50 was seeded on the opposite side. After a 1-hour incubation at room temperature, the number of viable worms was assessed by measuring their mobility. At least three biological replicates were performed for each experiment.
The viability of C. elegans was also measured after preincubation of the worms with E.coli K12 or E.coli JW3205 for five minutes. Subsequently, the worms were exposed to 2.5 mM H2O2 for 2, 4, 6, and 24 hours. The viability of the worms was assessed by measuring their mobility using the previously described method.
Viability of E. histolytica trophozoites exposed to S-nitrosoglutathione
E. histolytica trophozoites (1×106) in TYI-S-33 medium (without serum) were exposed to 350μM S-nitrosoglutathione (Sigma-Aldrich, St. Louis, MO, USA) for two hours at 37°C. The viability of the trophozoites was determined by the eosin dye exclusion method.
Physical separation of E. histolytica and E. coli during their exposure to H2O2
E. histolytica trophozoites (1×106) in 500 μl TYI-S-33 medium (without serum) were seeded into each well of a 24-well plate (Nunclon delta surface, Thermo Scientific, Israel). A polycarbonate SPL insert (0.4 μm) (SPL Biosciences, Israel) was introduced into each well and E. coli O55 or E. coli K12 (1×109 bacteria in 500 μl TYI-S-33 medium (without serum)) were introduced into the SPL insert. No bacteria were introduced in the SPL insert of the control trophozoite culture. Oxidative stress was generated in some wells by adding 2.5 mM H2O2 directly into the SPL insert. The viability of the trophozoites was determined by the eosin dye exclusion method.
Measurement of the cytopathic activity of E. histolytica
The cytopathic activity of E. histolytica trophozoites was determined using a previously described protocol .
Assessment of amebicidal activity by murine RAW 264.7 macrophages in presence or absence of oxaloacetate
The amebicidal activity of activated murine macrophages was determined using previously described protocol . Briefly, RAW 267.7 macrophages (a kind gift from Dr. Moran Benhar, Faculty of Medicine, Technion) were activated by a 22-hour incubation with lipopolysaccharides (LPS) (1 μg/μl) and interferon γ (INF-γ) (100 U/ml) in absence of presence of oxaloacetate (2mM). Activated macrophages (2 × 106/ml) and E. histolytica trophozoites (2 × 104/ml) were co-incubated at 37°C for six hours. The viability of trophozoites was determined by the eosin dye exclusion method .
C57BL/6 and CBA/J mice were purchased from the Jackson Laboratory (Japan). The mice were maintained under specific pathogen-free conditions.
Parasites and intracecal inoculation in mice
Trophozoites for intracecal injections were originally derived from laboratory strain HM1:IMSS (American Type Culture Collection) that were sequentially passaged in vivo through the mouse cecum . For all intracecal injections, axenic trophozoites were grown to the log phase and counted with a hemacytometer, and 1 × 106 trophozoites in 200 μl TYI-S-33 medium were injected in the presence or absence of oxaloacetate (2 mM) into the proximal, middle, and apical regions of the cecum  of mice anesthetized with Domitor (medetomidine hydrochloride, 0.1 mg/kg) and Dormicum (midazolam, 0.1 mg/kg). At the end of the experiment, mice were sacrificed by barbiturate overdose.
We anesthetized mice with Domitor (medetomidine hydrochloride, 0.1 mg/kg) and Dormicum (midazolam, 0.1 mg/kg). Mice were sacrified by Barbiturate overdose. All experiments that involved mice were reviewed and approved by the Committee for Ethics on Animal Experiments in the Graduate School of Gunma University, and were conducted under the control of the Guidelines for Animal Experiments in the Graduate School of Medicine, Gunma University, and the Law (No. 105) and Notification (No. 6) of the Japanese Government. The protocol number 16–041 has been assigned by the Committee for Ethics on Animal Experiments in the Graduate School of Gunma University after approval of the animal experiments described in this study.
Detection and quantification of E. histolytica in infected mice
QIAamp DNA stool kits (Qiagen, Valencia, CA) was used for DNA extraction from the mice feces according to the manufacturer’s instructions. To quantify the presence of E.histolytica trophozoites in stool, real-time quantitative PCR was performed by using using SYBR Green Supermix (Life Technologies, TA, CA, USA) in the Quant Studio 7 Flex Real-Time PCR System (Applied Biosystems®, Life Technologies, CA, USA). Primer sets specific to E.histolytica 18S rRNA were EntaF and EhR (S8 Table). To make a standard curve, DNA extracted from E.histolytica trophozoites was serially diluted from 105 to 100. Based on the standard curve and the stool weight, the number of trophozoite/mg stool was calculated. The presence of live trophozoites in the stool was confirmed by cultivation of stool in TYI-S-33 medium in presence of 103 unit/ml penicillin G, 1 mg/ml streptomycin, and 2.5 μg/ml amphotericin B.
Preparation of E. coli total lysate
Overnight cultures of E. coli were diluted 100-fold in 10 ml of fresh LB medium and incubated at 37°C until the OD600 reached 0.5. The cells were then harvested by centrifugation, washed once with phosphate-buffered saline, and finally re-suspended in 500 μl buffer which contained 0.1M Tris (pH 7.4), 2 mM EDTA, 0.2M DTT, and 0.5mM PMSF. The cells were lysed by ultrasonic disintegration using an ultrasonic disintegrator (Topas GmbH) which was operated five times for ten seconds at 50% output power at 4°C. The resultant homogenates were centrifuged at 15,000×g for 15 minutes at 4°C, and the supernatants were used for measuring the MDH activity.
Isolation of E. histolytica trophozoites secreted products
Proteins secreted by E.histolytica trophozoites were isolated using a previously described protocol .
Determination of MDH activity
Enzyme assays were performed in a 1-cm cuvette which contained 890 μl MDH assay buffer (50 mM Tris buffer and 2 mM NAD+) and 10 μl of test sample. The reaction was initiated by the addition of 100 μl L-malate (500mM) and the rate of formation of the reduced form of nicotinamide adenine dinucleotide (NADH) was monitored at 340 nm using spectrophotometer (Pharmacia Biotech Ultrospec 2000). One unit of MDH activity is defined as 1 μmol of NAD+ converted to its reduced form/min/mg protein. The protein concentration was determined by the Bradford method .
The commercial E.coli His-tagged MDH was purchased from Abcam (Recombinant E.coli mdh protein ab124594). The recombinant E.coli MDH protein was diluted with MDH assay buffer to a concentration of 60 μg/ml. Viability of E. histolytica trophozoites preincubated with His-tagged EcMDH (1.5 μg) with or without malate (50 mM) was performed as described above.
DNA constructs and complementation
For the cloning of E. coli MDH, the E.coli MDH gene was amplified from E.coli genomic DNA using the E.coli MDH 5’ and E.coli MDH 3’ primers (S8 Table). The PCR product was sub-cloned using the pGEM-T easy vector system (Promega, Madison, Wisconsin, USA).
For construction of the pJST4-E. coli MDH expression vector that was used to express HA-tagged EcMDH in the parasite, a synthetic E. coli MDH gene was ordered (Synthezza, Israel). The synthetic gene was digested with the restriction enzymes KpnI and BamHI. The released MDH gene was cloned into the pJST4 vector that has been previously linearized with KpnI and BamHI restriction enzymes. The construction of the pcontrol plasmid, which was used in this investigation, has been previously described .
For complementation of the mutated E. coli strain JW3205 with E. coli MDH, E.coli MDH gene was amplified from E.coli genomic DNA using primers 5’ BamHI MDH and 3’ EcoRI MDH (S8 Table) and the PCR product was cloned in the pGEM-T easy vector. E. coli MDH was digested with BamHI and EcoRI and then cloned in the vector pGFP (Genbank accession No: U17997) which had been previously linearized with BamHI and EcoRI.
For complementation of the mutated E. coli strain JW3205 with E. histolytica MDH, the E. histolytica MDH gene was amplified from a PGEX-EhMDH vector using the primers EhMDH BamHI 5’and EhMDH EcoRI 3’(S8 Table). The PCR product was cloned in the pGEM-T easy vector. Eh MDH was digested with BamHI and EcoRI and then cloned in the pGFP vector (Genbank accession number: U17997) which had been previously linearized with BamHI and EcoRI.
Primers used in this study
Primers used in this study are displayed in S8 Table.
Detection of oxidized (OX) proteins by resin-assisted capture (RAC) (OX-RAC)
The detection of OXs by OX-RAC was performed using a previously described protocol. Captured proteins were eluted with 30 μl elution buffer which contained 10 mM HEPES, 0.1 mM EDTA, 0.01 mM neocuproine, 0.1% SDS and 100 mM 2-mercaptoethanol for 20 minutes at room temperature. Proteins in a 10-μl aliquot of each eluent were resolved on a 12.5% SDS-PAGE gel. Each gel was then stained with silver (Pierce Silver Stain) and each gel slice was independently analyzed by mass spectrometry (MS). A protein was considered to be oxidized when its relative amount in the dithiothreitol (DTT)-treated lysates was significantly less than that in the DTT-untreated lysates (p <0.05 according to the results of a unpaired t-test).
In gel proteolysis and mass spectrometry analysis
In gel proteolysis by trypsin and analysis by LC-MS/MS on Q Exactive plus (Thermo) and data analysis with MaxQuant 220.127.116.11  and the Uniprot database as the reference were done using a previously described protocol. The data was quantified by LF analysis using the same software. The identifications are filtered for proteins identified with a false discovery rate of <0.01 and at least two identified peptides in the project. The intensities are presented as raw intensities without normalization and as LFQ with normalization, both presented as log2 intensities.
Classification of OX-proteins according to their protein class
Detection of OX-Gal/GalNac lectin
Following the OX-RAC procedure, proteins in a 10 μl aliquot of each eluent were resolved on an 8% SDS-PAGE gel and stained with silver or transferred onto a nitrocellulose membrane (Whatman, Protran BA83). The blots were first blocked using 3% skim milk, and then probed with 1:500 rabbit polyclonal Gal/GalNAc lectin antibody (a kind gift from Dr. N. Guillen, Pasteur Institute, Paris, France) for 16 hours at 4°C. After incubation with the Gal/GalNac lectin antibody, the blots were incubated with 1:5000 secondary rabbit antibody for one hour at room temperature (Jackson ImmunoResearch), and then developed by enhanced chemiluminescence.
Detection of oxaloacetate
The detection of oxaloacetate in E. coli and in E. histolytica was done using a commercial enzymatic-based kit (Abcam, Zotal, Israel).
Ultraviolet (UV) spectrophotometric analysis of the stability of H2O2 in presence of oxaloacetate
Oxaloacetate (0.25 mM) and H2O2 (3.5 mM) in 10 mM phosphate buffer, pH 7.4, were mixed together at 25°C and the concentration of H2O2 was determined by UV spectrophotometric analysis according to a previously described protocol  on a UV spectrophotometer NanoDrop 2000c (Thermo Fisher Scientific, USA).
E. histolytica trophozoites were suspended in 2 ml ice cold methanol and transferred into a 4-ml tube which contained glass beads (0.10–0.11-mm diameter) (Sartorius AG). Cell disruption was performed by using a FastPrep-24 instrument (MP Biomedicals, LLC) twice for 40 seconds each at 6.0 m/s. Methanolic cell extract was transferred to 15-ml tubes after centrifugation for five minutes at 4°C. Cell debris and glass beads were washed twice with 1 ml ultrapure water as a second extraction step.
The aqueous and methanolic cell extracts were combined. An aliquot (0.4 ml) of chloroform was added to the cell extracts and the suspension was vortexed and shaken five times for ten seconds. For separation of the aqueous and organic layers, the samples were stored at -20°C for ten minutes. After centrifugation for five minutes at 4°C and 10,015g, the upper layer was transferred to a 50-ml tube, diluted with water, and stored at -80°C for lyophilization.
Gas chromatography–mass spectrometry (GC-MS) analysis
Derivatization of lyophilized samples was done using a previously described protocol. Analysis was performed by using an Agilent 7890B GC system with an autosampler (model G4513A), and a coupled mass selective detector (model 5977B MSD) (Agilent). The 2-μl injection volume of the sample was split 1:10 at 250°C with an inlet split flow of 10 ml/min. Helium was used as the carrier gas at a pressure of 8.8 lb/in2. Chromatographic separation on a 30-m HP 5-ms column (Agilent Technologies) with a 0.25-mm inner diameter and a 2.5-μm film thickness was performed at a constant gas flow of 1 ml/min. The oven program started with an initial temperature which was held at 70°C for one minute, continued at a heating rate of 1.5°C/minute up to 76°C, followed by heating at 5°C/minute up to 220°C, and 20°C/minute up to 325°C, with a hold time of eight minutes. The analytes were transferred to the mass selective detector via the transfer line at 325°C and ionized by electron impact ionization at 230°C. After a solvent delay of six minutes, mass spectra were acquired using a quadrupole temperature of 150°C and SIM acquisition mode., The selected quantifier ion for glycerol was m/z 205.1 and for isocitrate was m/z 245.1.
Data analysis was done by using MassHunter Workstation software Quantitative Analysis 8.0. The area of the quantifier ion of each metabolite was integrated and normalized to the area of the quantifier ion of one internal standard (glycerol and isocitrate were normalized to p-chlorophenylalanine). This ratio represents the relative metabolite amount and was normalized to the protein content of the sample.
S3 Table. PANTHER sequence classification of OX-proteins.
S4 Table. Common OX-proteins in trophozoites incubated with heat-killed or live E.coli O55.
S5 Table. Enriched OX-proteins according to the PANTHER sequence classification tool.
S6 Table. E. coli proteins co-purified with E.histolytica OX-proteins.
S7 Table. Bacterial strains used in this study.
S1 Fig. Viability of E. histolytica trophozoites exposed to different concentrations of oxaloacetate prior to their exposure to 2.5 mM H2O2.
Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice. (Unpaired t-test, * P ≤0.05).
S2 Fig. Viability of E. histolytica trophozoites exposed to 0.5 mM oxaloacetate prior to their exposure to 2.5 mM paraquat.
Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice. Trophozoites vs Trophozoites + Paraquat (Unpaired t-test, *** P ≤0.001), Trophozoites vs Trophozoites+Oxaloacetate+Paraquat (Unpaired t-test, *** P ≤0.001).
S3 Fig. Viability of E. histolytica trophozoites exposed to different concentration of oxaloacetate prior to their exposure to 350 μM S-nitrosoglutathione.
Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice.
S4 Fig. The protection of E.histolytica against OS by E.coli is contact-independent.
E.histolytica trophozoites and E.coli K12 or E.coli O55 were physically separated by a polycarbonate insert (0.4μm) prior to their exposure to oxidative stress. Data are displayed as the mean ± standard deviation of three independent experiments that were repeated twice. Trophozoites vs Trophozoites + H2O2 (Unpaired t-test, ** P ≤0.01).
S5 Fig. Spectrophotometric analysis of the stability of H2O2 in presence of oxaloacetate.
The absorbance of H2O2 is followed at 225 nm.
S6 Fig. Coomassie blue staining of proteins secreted by E.histolytica trophozoites.
Lane 1: Molecular weight marker (SMOBIO-PM-2600). Lane 2: Proteins secreted by E.histolytica trophozoites (20 μg).
S7 Fig. Amount of Hgl in the total lysate of trophozoites exposed to H2O2 or to H2O2 and oxaloacetate.
Proteins (40 μg) present in a lysate of trophozoites exposed to H2O2 or to H2O2 and oxaloacetate were separated on 8% SDS-PAGE gels and analyzed by western blotting using a polyclonal Gal/GalNAc lectin antibody. The figure displays a representative result from two independent experiments. Cell lysates of trophozoites exposed to H2O2 (2.5 mM) (lane 1) to H2O2 (2.5 mM) and oxaloacetate (2 mM) (lane 2) for 30 minutes (input control for the data presented in Fig 4).
We thank Orna Ben-Naim Zgayer for her help with the C. elegans experiments. This work is dedicated to Professor David Mirelman (Weizmann Institute, Israel) who introduced us to the field of amebiasis through his interest in bacteria and E. histolytica.
- 1. Turkeltaub JA, McCarty TR 3rd, Hotez PJ. The intestinal protozoa: emerging impact on global health and development. Curr Opin Gastroenterol. 2015;31(1):38–44. Epub 2014/11/14. pmid:25394233.
- 2. Lohia A. The cell cycle of Entamoeba histolytica. Mol Cell Biochem. 2003;253(1–2):217–22. Epub 2003/11/19. PubMed pmid:14619972.
- 3. Stanley SL Jr., Reed SL. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions. Am J Physiol Gastrointest Liver Physiol. 2001;280(6):G1049–54. Epub 2001/05/16. pmid:11352795.
- 4. Huston CD, Petri WA Jr.. Host-pathogen interaction in amebiasis and progress in vaccine development. Eur J Clin Microbiol Infect Dis. 1998;17(9):601–14. Epub 1998/12/01. PubMed pmid:9832261.
- 5. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8):e1002533. Epub 2016/08/20. PBIOLOGY-D-16-00889 [pii]. pmid:27541692; PubMed Central PMCID: PMC4991899.
- 6. Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immunol. 2004;5(6):569–73. Epub 2004/05/28. ni1079 [pii]. pmid:15164016.
- 7. Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci U S A. 2003;100(18):10452–9. Epub 2003/08/19. 1734063100 [pii]. pmid:12923294; PubMed Central PMCID: PMC193582.
- 8. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A. 1998;95(12):6578–83. Epub 1998/06/17. PubMed pmid:9618454; PubMed Central PMCID: PMC33863.
- 9. Mirelman D. Effect of culture conditions and bacterial associates on the zymodemes of Entamoeba histolytica. Parasitol Today. 1987;3(2):37–40; discussion 37. Epub 1987/02/01. doi: 0169-4758(87)90210-9 [pii]. PubMed pmid:15462903.
- 10. Mirelman D, Feingold C, Wexler A, Bracha R. Interactions between Entamoeba histolytica, bacteria and intestinal cells. Ciba Found Symp. 1983;99:2–30. Epub 1983/01/01. PubMed pmid:6315320.
- 11. Verma AK, Verma R, Ahuja V, Paul J. Real-time analysis of gut flora in Entamoeba histolytica infected patients of Northern India. BMC Microbiol. 2012;12:183. Epub 2012/08/24. 1471-2180-12-183 [pii]. pmid:22913622; PubMed Central PMCID: PMC3534334.
- 12. Burgess SL, Petri WA Jr. The Intestinal Bacterial Microbiome and E. histolytica Infection. Curr Trop Med Rep. 2016;3:71–4. Epub 2016/08/16. 83 [pii]. pmid:27525214; PubMed Central PMCID: PMC4967426.
- 13. Kedia S, Rampal R, Paul J, Ahuja V. Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India. J Gastroenterol. 2016;51(7):660–71. Epub 2016/03/21. 10.1007/s00535-016-1193-1 [pii]. pmid:26994772.
- 14. Thibeaux R, Weber C, Hon CC, Dillies MA, Ave P, Coppee JY, et al. Identification of the Virulence Landscape Essential for Entamoeba histolytica Invasion of the Human Colon. PLoS Pathog. 2013;9(12):e1003824. Epub 2014/01/05. PPATHOGENS-D-13-01573 [pii]. pmid:24385905; PubMed Central PMCID: PMC3868522.
- 15. Paniagua GL, Monroy E, Garcia-Gonzalez O, Alonso J, Negrete E, Vaca S. Two or more enteropathogens are associated with diarrhoea in Mexican children. Ann Clin Microbiol Antimicrob. 2007;6:17. Epub 2007/12/29. doi: 1476-0711-6-17 [pii]. pmid:18162140; PubMed Central PMCID: PMC2246149.
- 16. Bracha R, Mirelman D. Virulence of Entamoeba histolytica trophozoites. Effects of bacteria, microaerobic conditions, and metronidazole. J Exp Med. 1984;160(2):353–68. Epub 1984/08/01. PubMed pmid:6088660; PubMed Central PMCID: PMC2187461.
- 17. Padilla-Vaca F, Ankri S, Bracha R, Koole LA, Mirelman D. Down regulation of Entamoeba histolytica virulence by monoxenic cultivation with Escherichia coli O55 is related to a decrease in expression of the light (35-kilodalton) subunit of the Gal/GalNAc lectin. Infect Immun. 1999;67(5):2096–102. Epub 1999/05/04. PubMed pmid:10225860; PubMed Central PMCID: PMC115943.
- 18. Gilchrist CA, Petri SE, Schneider BN, Reichman DJ, Jiang N, Begum S, et al. Role of the Gut Microbiota of Children in Diarrhea Due to the Protozoan Parasite Entamoeba histolytica. J Infect Dis. 2016;213(10):1579–85. Epub 2015/12/30. jiv772 [pii]. pmid:26712950; PubMed Central PMCID: PMC4837909.
- 19. Burgess SL, Buonomo E, Carey M, Cowardin C, Naylor C, Noor Z, et al. Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis. MBio. 2014;5(6):e01817. Epub 2014/11/06. e01817-14 [pii]mBio.01817-14 [pii]. PubMed Central PMCID: PMC4222101. pmid:25370489
- 20. Rastew E, Vicente JB, Singh U. Oxidative stress resistance genes contribute to the pathogenic potential of the anaerobic protozoan parasite, Entamoeba histolytica. Int J Parasitol. 2012;42(11):1007–15. Epub 2012/09/27. S0020-7519(12)00220-2 [pii]. pmid:23009748; PubMed Central PMCID: PMC3483436.
- 21. Santi-Rocca J, Smith S, Weber C, Pineda E, Hon CC, Saavedra E, et al. Endoplasmic reticulum stress-sensing mechanism is activated in Entamoeba histolytica upon treatment with nitric oxide. PLoS One. 2012;7(2):e31777. pmid:22384074; PubMed Central PMCID: PMCPMC3286455.
- 22. Shahi P, Trebicz-Geffen M, Nagaraja S, Alterzon-Baumel S, Hertz R, Methling K, et al. Proteomic Identification of Oxidized Proteins in Entamoeba histolytica by Resin-Assisted Capture: Insights into the Role of Arginase in Resistance to Oxidative Stress. PLoS Negl Trop Dis. 2016;10(1):e0004340. Epub 2016/01/07. PNTD-D-15-01454 [pii]. pmid:26735309; PubMed Central PMCID: PMC4703340.
- 23. Hertz R, Ben Lulu S, Shahi P, Trebicz-Geffen M, Benhar M, Ankri S. Proteomic Identification of S-Nitrosylated Proteins in the Parasite Entamoeba histolytica by Resin-Assisted Capture: Insights into the Regulation of the Gal/GalNAc Lectin by Nitric Oxide. PLoS One. 2014;9(3). doi: ARTN e91518 PubMed PMID: ISI:000332851300096.
- 24. Tekwani BL, Mehlotra RK. Molecular basis of defence against oxidative stress in Entamoeba histolytica and Giardia lamblia. Microbes Infect. 1999;1(5):385–94. Epub 1999/12/22. doi: S1286-4579(99)80055-0 [pii]. PubMed pmid:10602671.
- 25. Li X, Shang Q, Gao Z, Hao F, Guo H, Guo C. Fecal microbiota transplantation (FMT) could reverse the severity of experimental necrotizing enterocolitis (NEC) via oxidative stress modulation. Free Radic Biol Med. 2017;108:32–43. Epub 2017/03/23. doi: S0891-5849(17)30135-1 [pii] pmid:28323128.
- 26. Tomasello G, Mazzola M, Leone A, Sinagra E, Zummo G, Farina F, et al. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(4):461–6. Epub 2016/11/05. pmid:27812084.
- 27. Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 2014;94(2):329–54. Epub 2014/04/03. 94/2/329 [pii]. pmid:24692350; PubMed Central PMCID: PMC4044300.
- 28. Mardinoglu A, Shoaie S, Bergentall M, Ghaffari P, Zhang C, Larsson E, et al. The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol Syst Biol. 2015;11(10):834. Epub 2015/10/18. pmid:26475342; PubMed Central PMCID: PMC4631205.
- 29. Saint-Georges-Chaumet Y, Edeas M. Microbiota-mitochondria inter-talk: consequence for microbiota-host interaction. Pathog Dis. 2016;74(1):ftv096. Epub 2015/10/27. ftv096 [pii]. pmid:26500226.
- 30. Varet H, Shaulov Y, Sismeiro O, Trebicz-Geffen M, Legendre R, Coppee JY, et al. Enteric bacteria boost defences against oxidative stress in Entamoeba histolytica. Sci Rep. 2018;8(1):9042. Epub 2018/06/15. pmid:29899530.
- 31. Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45(D1):D183–D9. Epub 2016/12/03. gkw1138 [pii]. pmid:27899595; PubMed Central PMCID: PMC5210595.
- 32. Bracha R, Mirelman D. Virulence of Entamoeba histolytica trophozoites. Effects of bacteria, microaerobic conditions, and metronidazole. J Exp Med. 1984;160(2):353–68. Epub 1984/08/01. PubMed pmid:6088660; PubMed Central PMCID: PMC2187461.
- 33. Farr SB, Kogoma T. Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol Rev. 1991;55(4):561–85. Epub 1991/12/01. PubMed pmid:1779927; PubMed Central PMCID: PMC372838.
- 34. Maguire M, Coates AR, Henderson B. Chaperonin 60 unfolds its secrets of cellular communication. Cell Stress Chaperones. 2002;7(4):317–29. Epub 2003/03/26. PubMed pmid:12653476; PubMed Central PMCID: PMC514831.
- 35. Baez A, Shiloach J. Escherichia coli avoids high dissolved oxygen stress by activation of SoxRS and manganese-superoxide dismutase. Microb Cell Fact. 2013;12:23. Epub 2013/03/19. 1475-2859-12-23 [pii]. pmid:23497217; PubMed Central PMCID: PMC3605374.
- 36. Oh TJ, Kim IG, Park SY, Kim KC, Shim HW. NAD-dependent malate dehydrogenase protects against oxidative damage in Escherichia coli K-12 through the action of oxaloacetate. Environ Toxicol Pharmacol. 2002;11(1):9–14. Epub 2002/01/01. doi: S1382-6689(01)00093-X [pii]. PubMed pmid:21782581.
- 37. Baillon ML, van Vliet AH, Ketley JM, Constantinidou C, Penn CW. An iron-regulated alkyl hydroperoxide reductase (AhpC) confers aerotolerance and oxidative stress resistance to the microaerophilic pathogen Campylobacter jejuni. J Bacteriol. 1999;181(16):4798–804. Epub 1999/08/10. PubMed pmid:10438747; PubMed Central PMCID: PMC93964.
- 38. Tkachenko AG, Akhova AV, Shumkov MS, Nesterova LY. Polyamines reduce oxidative stress in Escherichia coli cells exposed to bactericidal antibiotics. Res Microbiol. 2012;163(2):83–91. Epub 2011/12/06. S0923-2508(11)00186-0 [pii]. pmid:22138596.
- 39. Dip PV, Kamariah N, Nartey W, Beushausen C, Kostyuchenko VA, Ng TS, et al. Key roles of the Escherichia coli AhpC C-terminus in assembly and catalysis of alkylhydroperoxide reductase, an enzyme essential for the alleviation of oxidative stress. Biochim Biophys Acta. 2014;1837(12):1932–43. Epub 2014/09/07. doi: S0005-2728(14)00581-7 [pii] pmid:25193562.
- 40. Husain A, Sato D, Jeelani G, Soga T, Nozaki T. Dramatic increase in glycerol biosynthesis upon oxidative stress in the anaerobic protozoan parasite Entamoeba histolytica. PLoS Negl Trop Dis. 2012;6(9):e1831. Epub 2012/10/03. PNTD-D-12-00389 [pii]. pmid:23029590; PubMed Central PMCID: PMC3459822.
- 41. Shahi P, Trebicz-Geffen M, Nagaraja S, Hertz R, Alterzon-Baumel S, Methling K, et al. N-acetyl ornithine deacetylase is a moonlighting protein and is involved in the adaptation of Entamoeba histolytica to nitrosative stress. Sci Rep. 2016;6:36323. Epub 2016/11/04. srep36323 [pii]. pmid:27808157; PubMed Central PMCID: PMC5093748.
- 42. Bracha R, Mirelman D. Virulence of Entamoeba-Histolytica Trophozoites—Effects of Bacteria, Microaerobic Conditions, and Metronidazole. J Exp Med. 1984;160(2):353–68. PubMed PMID: ISI:A1984TD25700001. pmid:6088660
- 43. Nirujogi RS, Muthusamy B, Kim MS, Sathe GJ, Lakshmi PT, Kovbasnjuk ON, et al. Secretome analysis of diarrhea-inducing strains of Escherichia coli. Proteomics. 2017;17(6). Epub 2017/01/11. pmid:28070933; PubMed Central PMCID: PMC5545895.
- 44. Loftus B, Anderson I, Davies R, Alsmark UC, Samuelson J, Amedeo P, et al. The genome of the protist parasite Entamoeba histolytica. Nature. 2005;433(7028):865–8. Epub 2005/02/25. doi: nature03291 [pii] pmid:15729342.
- 45. Ahn CS, Kim JG, Shin MH, Lee YA, Kong Y. Comparison of Secretome Profile of Pathogenic and Non-Pathogenic Entamoeba histolytica. Proteomics. 2018;18(7):e1700341. Epub 2018/02/07. pmid:29409117.
- 46. Nath KA, Ngo EO, Hebbel RP, Croatt AJ, Zhou B, Nutter LM. alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am J Physiol. 1995;268(1 Pt 1):C227–36. Epub 1995/01/01. pmid:7840152.
- 47. Lopalco A, Dalwadi G, Niu S, Schowen RL, Douglas J, Stella VJ. Mechanism of Decarboxylation of Pyruvic Acid in the Presence of Hydrogen Peroxide. J Pharm Sci. 2016;105(2):705–13. Epub 2015/10/01. doi: S0022-3549(15)00088-X [pii] pmid:26422524; PubMed Central PMCID: PMC4814373.
- 48. Dodson JM, Lenkowski PW Jr., Eubanks AC, Jackson TF, Napodano J, Lyerly DM, et al. Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin. J Infect Dis. 1999;179(2):460–6. Epub 1999/01/07. doi: JID980955 [pii] pmid:9878032.
- 49. Lin JY, Chadee K. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. J Immunol. 1992;148(12):3999–4005. Epub 1992/06/15. PubMed pmid:1318338.
- 50. Hamano S, Asgharpour A, Stroup SE, Wynn TA, Leiter EH, Houpt E. Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production. J Immunol. 2006;177(2):1208–13. Epub 2006/07/05. doi: 177/2/1208 [pii]. PubMed pmid:16818779.
- 51. Shimokawa C, Senba M, Kobayashi S, Kikuchi M, Obi S, Olia A, et al. Intestinal Inflammation-Mediated Clearance of Amebic Parasites Is Dependent on IFN-gamma. J Immunol. 2018;200(3):1101–9. Epub 2017/12/20. jimmunol.1700806 [pii]. pmid:29255076.
- 52. Williams DS, Cash A, Hamadani L, Diemer T. Oxaloacetate supplementation increases lifespan in Caenorhabditis elegans through an AMPK/FOXO-dependent pathway. Aging Cell. 2009;8(6):765–8. Epub 2009/10/02. ACE527 [pii]. pmid:19793063; PubMed Central PMCID: PMC2988682.
- 53. Hertz R, Ben Lulu S, Shahi P, Trebicz-Geffen M, Benhar M, Ankri S. Proteomic identification of S-nitrosylated proteins in the parasite Entamoeba histolytica by resin-assisted capture: insights into the regulation of the Gal/GalNAc lectin by nitric oxide. PLoS One. 2014;9(3):e91518. Epub 2014/03/15. PONE-D-13-51231 [pii]. pmid:24626316; PubMed Central PMCID: PMC3953491.
- 54. Mares RE, Minchaca AZ, Villagrana S, Melendez-Lopez SG, Ramos MA. Analysis of the isomerase and chaperone-like activities of an amebic PDI (EhPDI). Biomed Res Int. 2015;2015:286972. Epub 2015/02/20. pmid:25695056; PubMed Central PMCID: PMC4324885.
- 55. Pacheco-Yepez J, Jarillo-Luna RA, Gutierrez-Meza M, Abarca-Rojano E, Larsen BA, Campos-Rodriguez R. Peroxynitrite and peroxiredoxin in the pathogenesis of experimental amebic liver abscess. Biomed Res Int. 2014;2014:324230. Epub 2014/05/14. pmid:24822193; PubMed Central PMCID: PMC4009108.
- 56. Jung T, Hohn A, Grune T. The proteasome and the degradation of oxidized proteins: Part II—protein oxidation and proteasomal degradation. Redox Biol. 2014;2:99–104. Epub 2014/12/03. S2213-2317(13)00096-7 [pii]. pmid:25460724; PubMed Central PMCID: PMC4297946.
- 57. Perri ER, Thomas CJ, Parakh S, Spencer DM, Atkin JD. The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration. Front Cell Dev Biol. 2015;3:80. Epub 2016/01/19. pmid:26779479; PubMed Central PMCID: PMC4705227.
- 58. Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med. 2014;66:75–87. Epub 2013/08/01. S0891-5849(13)00380-8 [pii]. pmid:23899494.
- 59. Desagher S, Cordier J, Glowinski J, Tence M. Endothelin stimulates phospholipase D in striatal astrocytes. J Neurochem. 1997;68(1):78–87. Epub 1997/01/01. PubMed pmid:8978712.
- 60. Sokolowska M, Oleszek A, Wlodek L. Protective effect of alpha-keto acids on the oxidative hemolysis. Pol J Pharmacol. 1999;51(5):429–34. Epub 2000/05/19. PubMed pmid:10817544.
- 61. Andrae U, Singh J, Ziegler-Skylakakis K. Pyruvate and related alpha-ketoacids protect mammalian cells in culture against hydrogen peroxide-induced cytotoxicity. Toxicol Lett. 1985;28(2–3):93–8. PubMed pmid:4071565.
- 62. O'Donnell-Tormey J, Nathan CF, Lanks K, DeBoer CJ, de la Harpe J. Secretion of pyruvate. An antioxidant defense of mammalian cells. J Exp Med. 1987;165(2):500–14. PubMed pmid:3102672; PubMed Central PMCID: PMCPMC2188509.
- 63. Raj D, Chowdhury P, Sarkar R, Saito-Nakano Y, Okamoto K, Dutta S, et al. Pyruvate Protects Giardia Trophozoites from Cysteine-Ascorbate Deprived Medium Induced Cytotoxicity. Korean J Parasitol. 2018;56(1):1–9. Epub 2018/03/14. kjp-56-1-1 [pii]. pmid:29529844; PubMed Central PMCID: PMC5858663.
- 64. Cavallini L, Valente M, Rigobello MP. The protective action of pyruvate on recovery of ischemic rat heart: comparison with other oxidizable substrates. J Mol Cell Cardiol. 1990;22(2):143–54. PubMed pmid:2182887.
- 65. Salahudeen AK, Clark EC, Nath KA. Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest. 1991;88(6):1886–93. pmid:1752950; PubMed Central PMCID: PMCPMC295757.
- 66. Crestanello JA, Kamelgard J, Whitman GJ. The cumulative nature of pyruvate's dual mechanism for myocardial protection. J Surg Res. 1995;59(1):198–204. pmid:7630128.
- 67. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A. 1992;89(1):444–8. Epub 1992/01/01. PubMed pmid:1346070; PubMed Central PMCID: PMC48254.
- 68. Fukushima T, Tanaka K, Lim H, Moriyama M. Mechanism of cytotoxicity of paraquat. Environ Health Prev Med. 2002;7(3):89–94. Epub 2002/07/01. pmid:21432289; PubMed Central PMCID: PMC2723489.
- 69. Chassagnole C, Noisommit-Rizzi N, Schmid JW, Mauch K, Reuss M. Dynamic modeling of the central carbon metabolism of Escherichia coli. Biotechnol Bioeng. 2002;79(1):53–73. Epub 2007/06/27. PubMed pmid:17590932.
- 70. Tovy A, Siman Tov R, Gaentzsch R, Helm M, Ankri S. A new nuclear function of the Entamoeba histolytica glycolytic enzyme enolase: the metabolic regulation of cytosine-5 methyltransferase 2 (Dnmt2) activity. PLoS Pathog. 2010;6(2):e1000775. Epub 2010/02/23. pmid:20174608; PubMed Central PMCID: PMC2824750.
- 71. Biller L, Matthiesen J, Kuhne V, Lotter H, Handal G, Nozaki T, et al. The cell surface proteome of Entamoeba histolytica. Mol Cell Proteomics. 2014;13(1):132–44. Epub 2013/10/19. M113.031393 [pii]. pmid:24136294; PubMed Central PMCID: PMC3879609.
- 72. Pineda E, Encalada R, Rodriguez-Zavala JS, Olivos-Garcia A, Moreno-Sanchez R, Saavedra E. Pyruvate:ferredoxin oxidoreductase and bifunctional aldehyde-alcohol dehydrogenase are essential for energy metabolism under oxidative stress in Entamoeba histolytica. Febs J. 2010;277(16):3382–95. Epub 2010/07/16. EJB7743 [pii]. pmid:20629749.
- 73. Asgharpour A, Gilchrist C, Baba D, Hamano S, Houpt E. Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1+ cells. Infect Immun. 2005;73(8):4522–9. Epub 2005/07/26. doi: 73/8/4522 [pii] pmid:16040963; PubMed Central PMCID: PMC1201199.
- 74. Denis M, Chadee K. Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Infect Immun. 1989;57(6):1750–6. Epub 1989/06/01. PubMed pmid:2542164; PubMed Central PMCID: PMC313351.
- 75. Kato K, Takegawa Y, Ralston KS, Gilchrist CA, Hamano S, Petri WA Jr., et al. Sialic acid-dependent attachment of mucins from three mouse strains to Entamoeba histolytica. Biochem Biophys Res Commun. 2013;436(2):252–8. Epub 2013/06/04. S0006-291X(13)00892-9 [pii]. pmid:23726913; PubMed Central PMCID: PMC3734206.
- 76. Gao X, Pujos-Guillot E, Sebedio JL. Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010;82(15):6447–56. Epub 2010/07/31. pmid:20669995.
- 77. Meisel JD, Panda O, Mahanti P, Schroeder FC, Kim DH. Chemosensation of bacterial secondary metabolites modulates neuroendocrine signaling and behavior of C. elegans. Cell. 2014;159(2):267–80. Epub 2014/10/11. S0092-8674(14)01160-X [pii]. pmid:25303524; PubMed Central PMCID: PMC4194030.
- 78. Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517–26. Epub 2011/05/03. S1550-4131(11)00143-4 [pii]. pmid:21531334; PubMed Central PMCID: PMC3099420.
- 79. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–2. Epub 1978/01/01. PubMed pmid:212851.
- 80. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol. 1951;62(3):293–300. Epub 1951/09/01. PubMed pmid:14888646; PubMed Central PMCID: PMC386127.
- 81. Brenner S. The Genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. pmid:4366476
- 82. Olvera A, Olvera F, Vines RR, Recillas-Targa F, Lizardi PM, Dhar S, et al. Stable transfection of Entamoeba histolytica trophozoites by lipofection. Arch Med Res. 1997;28 Spec No:49–51. Epub 1997/01/01. PubMed pmid:9033009.
- 83. Ferreira SR, Mendes TA, Bueno LL, de Araujo JV, Bartholomeu DC, Fujiwara RT. A new methodology for evaluation of nematode viability. Biomed Res Int. 2015;2015:879263. Epub 2015/04/14. pmid:25866820; PubMed Central PMCID: PMC4383492.
- 84. Trebicz-Geffen M, Shahi P, Nagaraja S, Vanunu S, Manor S, Avrahami A, et al. Identification of S-Nitrosylated (SNO) Proteins in Entamoeba histolytica Adapted to Nitrosative Stress: Insights into the Role of SNO Actin and In vitro Virulence. Front Cell Infect Microbiol. 2017;7:192. Epub 2017/06/08. pmid:28589096; PubMed Central PMCID: PMC5440460.
- 85. Houpt ER, Glembocki DJ, Obrig TG, Moskaluk CA, Lockhart LA, Wright RL, et al. The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4(+) T cells. Journal of Immunology. 2002;169(8):4496–503. PubMed PMID: ISI:000178512000056.
- 86. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54. PubMed pmid:942051.
- 87. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367–72. Epub 2008/11/26. [pii]. pmid:19029910.
- 88. Dorries K, Schlueter R, Lalk M. Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus. Antimicrob Agents Chemother. 2014;58(12):7151–63. Epub 2014/09/17. AAC.03104-14 [pii]. pmid:25224006; PubMed Central PMCID: PMC4249544.
- 89. Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18(1):529. Epub 2017/12/01. 10.1186/s12859-017-1934-z [pii]. pmid:29187165; PubMed Central PMCID: PMC5708080.